Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Despite considerable efforts to promote early identification and treatment of sepsis, each year several million individuals worldwide develop sepsis-induced multiple organ dysfunction, requiring admission to intensive care and institution of life support, and frequently progressing to death or protracted illness and incomplete recovery. Sepsis is now the leading cause of death in US hospitals and is projected to account for more than 5 million deaths globally each year.1,2 The question is why. More specifically, why do patients with sepsis who receive appropriate antibiotics and prompt institution of life support still die? Certainly, there are instances when life support is inadequate, such as overwhelming shock unresponsive to fluids and vasopressors or severe hypoxia despite advanced mechanical ventilatory support. However, many critically ill patients simply lie in an ICU bed receiving life support while the team monitors for complications, titrates life support treatment, and waits to see what transpires.
Angus DC, Opal S. Immunosuppression and Secondary Infection in Sepsis: Part, Not All, of the Story. JAMA. 2016;315(14):1457–1459. doi:10.1001/jama.2016.2762
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: